Detection of decline in estimated glomerular filtration rate in patients with type 2 diabetes by cystatin C-based equations

Table 4 Clinical and laboratory characteristics of the study subjects

Characteristics		Type 2 diabetic		P value	Characteristics	Type 2 diabetic		P value
		Yes (n = 47)	No (n = 46)			Yes (n = 47)	No (n = 46)
Gender n, (%)	Male	15 (31.9)	18 (39.1)	0.47	HbA1c (%)	7.3 ± 1.7	5.8 ± 0.93	< 0.011
	Female	32 (68.1)	28 (60.9)		Glucose (mmol/L)	7.2 ± 2.7	5.5 ± 0.6	< 0.011
Average age (years)		71 ± 1.0	71 ± 1.2	0.82	Total cholesterol (mmol/L)	5.6 ± 0.9	5.6 ± 1.2	0.8
Weight (kg)		59.4 ± 13.4	57.3 ± 9.3	0.4	Triglycerides (mmol/L)	2.3 ± 0.9	2.1 ± 1.3	0.6
BMI (kg/m2)		24.3 ± 4.4	23.0 ± 2.7	0.08	HDL-C (mmol/L)	1.1 ± 0.27	1.1 ± 0.3	0.8
SBP (mmHg)		133 ± 14.2	129.7 ± 10.6	0.2	LDL-C (mmol/L)	3.6 ± 0.9	3.6 ± 1.0	1
DBP (mmHg)		82.2 ± 4.5	81.4 ± 5.0	0.4	Uric acid (μmol/L)	330 ± 75.6	315 ± 68.4	0.3
Scr (µmol/L)		84.9 ± 26.3	77.9 ± 20.1	0.15	Scys (mg/L)	1.3 ± 0.4	1.22 ± 0.3	0.3
ACR (mg/g)		17.4 (3.9 – 8632.3)2	13.5 (4 – 252.8)2	0.11

¹Student’s t-test.

²Median (minimum – maximum).

BMI: Body mass index; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; Scr: Serum creatinine; ACR: Albumin/creatinine ratio; HbA1c: Glycated hemoglobin; HDL-C: High-density lipoprotein cholesterol; LDL-C: Low-density lipoprotein cholesterol; Scys: Serum cystatin C.